Literature DB >> 34236635

Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins.

Eugene Varfolomeev1, Tatiana Goncharov1, Domagoj Vucic2.   

Abstract

Proper maintenance of organismal homeostasis, development, and immune defense requires precise regulation of survival and signaling pathways. Inhibitor of apoptosis (IAP) proteins are evolutionarily conserved regulators of cell death and immune signaling that impact numerous cellular processes. Although initially characterized as inhibitors of apoptosis, the ubiquitin ligase activity of IAP proteins is critical for modulating various signaling pathways (e.g., NF-κB, MAPK) and cell survival. Cellular IAP1 and 2 regulate the pro-survival canonical NF-κB pathway by ubiquitinating RIP1 and themselves thus enabling recruitment of kinase (IKK) and E3 ligase (LUBAC) complexes. On the other hand, c-IAP1 and c-IAP2 are negative regulators of noncanonical NF-κB signaling by promoting ubiquitination and consequent proteasomal degradation of the NF-κB-inducing kinase NIK. Here we describe the involvement of c-IAP1 and c-IAP2 in NF-κB signaling and provide detailed methodology for examining functional roles of c-IAPs in these pathways.

Entities:  

Keywords:  IAP; IAP antagonist; Inhibitor of apoptosis; NF-kB; NIK; Proteasomal degradation; RING domain; RIP1; TNF; TRAF2; Ubiquitin; c-IAP1/2

Mesh:

Substances:

Year:  2021        PMID: 34236635     DOI: 10.1007/978-1-0716-1669-7_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  40 in total

Review 1.  Polyubiquitin chains: polymeric protein signals.

Authors:  Cecile M Pickart; David Fushman
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

Review 2.  IAPs, RINGs and ubiquitylation.

Authors:  David L Vaux; John Silke
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

3.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 5.  Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.

Authors:  Eugene Varfolomeev; Domagoj Vucic
Journal:  Future Oncol       Date:  2011-05       Impact factor: 3.404

6.  Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Heather Maecker; Kerry Zobel; László G Kömüves; Kurt Deshayes; Domagoj Vucic
Journal:  Sci Signal       Date:  2012-03-20       Impact factor: 8.192

Review 7.  Targeting inhibitor of apoptosis proteins for therapeutic intervention.

Authors:  Chudi Ndubaku; Frederick Cohen; Eugene Varfolomeev; Domagoj Vucic
Journal:  Future Med Chem       Date:  2009-11       Impact factor: 3.808

Review 8.  Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Authors:  Domagoj Vucic; Vishva M Dixit; Ingrid E Wertz
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

9.  c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Anna V Fedorova; Jasmin N Dynek; Kerry Zobel; Kurt Deshayes; Wayne J Fairbrother; Domagoj Vucic
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

Review 10.  Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.

Authors:  J Silke; R Brink
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

View more
  1 in total

1.  IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition.

Authors:  Bruno Alicke; Eugene Varfolomeev; Shi Hui Kaylee Lee; Alexandra Frommlet; Savita Ubhayakar; John G Quinn; Wayne J Fairbrother; Robert Jones; Stephen E Gould; Domagoj Vucic
Journal:  Cell Death Dis       Date:  2022-09-28       Impact factor: 9.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.